Case No. | Age | Sex | Diagnosis | Follow-up period (Months) | Surgical procedure of the primary site | Resection length of the fibula (mm) | Amount of the grafted β-TCP (g) | Condition of the periosteum at the donor site | Infiltration of bone marrow aspirates | Postoperative symptom |
1 | 12 | F | Osteoid osteoma, rt. fibula | 23.8 | Wide resection | 71 | 2.5 | Excised | yes | no |
2 | 12 | F | CS, rt. femur | 178 | Wide resection, VFG | 188 | 14.4 | Excised | no | no |
3 | 13 | F | OS, lt. radius | 106 | Wide resection, VFG | 233 | 5.4 | Excised | yes | no |
4 | 21 | M | ABC, lt. femur | 2.36 | Curettage, NVFG | 101 | 2.3 | Preserved | no | no |
5 | 54 | F | GCTB, lt. tibia | 59.2 | Curettage, NVFG | 104 | 3.5 | Preserved | no | no |
6 | 55 | F | GCTB, lt. ischium | 10.8 | Wide resection, NVFG | 160 | 3.9 | Preserved | no | no |
7 | 18 | M | OS, rt. femur | 3.18 | Wide resection, NVFG, Irradiated bone graft | 219 | 7.3 | Preserved | no | no |
8 | 72 | F | UPS, lt. upper arm | 32.2 | Wide resection, NVFG | 132 | 10.4 | Preserved | no | no |
9 | 28 | F | FD, lt. femur | 20.1 | Curettage, NVFG | 104 | 3.5 | Preserved | no | no |
10 | 21 | F | SBC, rt. humerus | 13.8 | Curettage, NVFG | 170 | 13.1 | Preserved | no | no |
11 | 58 | M | CB, rt. femur | 13.5 | Curettage, NVFG | 180 | 13.1 | Preserved | no | no |
12 | 20 | M | GCTB, lt. femur | 17.8 | Curettage, NVFG | 133 | 4.6 | Preserved | no | no |
13 | 29 | M | FD, rt. femur | 69.3 | Curettage, NVFG | 106 | 3.5 | Preserved | no | Ankle pain |
14 | 14 | M | OS, lt. femur | 130 | Wide resection, prosthetic reconstruction augmented with NVFG | 133 | 3.1 | Preserved | no | no |
15 | 16 | F | SBC, rt. femur | 65.4 | Curettage, NVFG | 90 | 3.1 | Preserved | no | no |
16 | 10 | M | FD, lt. femur | 168 | Curettage, NVFG | 110 | 3.1 | Preserved | no | no |
17 | 9 | F | Histiocytic sarcoma, lt. thigh | 51.6 | Wide resection, NVFG, Irradiated bone graft | 126 | 4.2 | Preserved | no | no |